The OPTIMA Trial is still open to recruitment...
The OPTIMA trial remains open to recruitment during the COVID-19 epidemic. Patients with breast cancer who would usually be treated with chemotherapy may be able to avoid this through joining OPTIMA.
Many hospitals have asked their research teams to concentrate on COVID-19 research and as a result, have put recruitment to OPTIMA on hold for the time being. We are in the process of updating our list of hospitals offering OPTIMA. As our list may not be correct at present, please contact your local oncology team for more information.
OPTIMA is designed for patients with hormone-sensitive breast cancer. Please read our pages about the trial to find out if it might be suitable for you.